News

The market for brain-computer interfaces experienced a new round of competitive activity in recent weeks as new vendors entered the market and existing players introduced new enhancements to their offerings. One of the most significant developments involves new materials. INBRAIN Neuroelectronics, the Barcelona, Spain manufacturer of graphene-based brain implants, announced the first human implantation of its cortical interface in a patient undergoing brain tumor resection.

The LSX World Conference USA, held in Boston, MA earlier this month, brought together some key leaders in the neurotechnology and medical technology sectors for a dynamic event focused on innovation, partnerships, investment, and commercialization strategies. The conference featured sessions on industry trends, investment insights, and the regulatory landscape. Among the standout events was the keynote panel with Becton, Dickinson CSO, Joseph Smith.

As the neurotechnology industry enters its third decade, industry leaders would be wise to consider where the next generation of entrepreneurs and executives will come from. While government and nonprofit agencies such as the NIH and the NSF have played a major role in promoting and funding young neurotech researchers, success in a commercial setting requires a unique combination of technical, organizational, and entrepreneurial skills.

Neurotech researchers and commercial firms have developed a number of novel implants that have achieved commercial and clinical success as either a neurostimulation or neurosensing system. And while there are several examples of closed-loop systems, such as NeuroPace’s RNS device, that can perform both sensing and stimulation, that is generally the limit of multifunctionality. A spinoff from MIT ca…

The landscape of medical device coverage is ever-changing, influenced , evolving clinical evidence, and regulatory decisions. One such advancement is transcutaneous auricular vagus nerve stimulation, a novel therapy with a broad spectrum of potential applications, such as neurological diseases (chronic pain, epilepsy, migraine, and tinnitus) and psychiatric disorders (depression, PTSD, anxiety, substance abuse, and opioid withdrawal).

The 2024 NYC Neuromodulation Conference, held at City College New York earlier this month, brought scientists, engineers, and industry experts to explore the latest advancements in brain stimulation technologies. This annual event, a cornerstone in the field of neurotechnology, provides a fitting backdrop for discussions on cutting-edge topics. This year’s conference highlighted significant progres…

One of the most intriguing aspects of neuromodulation is the observed carry-over effects in certain applications, where the therapeutic benefits persist beyond the duration of stimulation. Recently, there have been a number of articles exploring the carry-over effect in peripheral nerve stimulation for the treatment of pain. Interestingly, this phenomenon has been well documented in peripheral nerve stimulation for overactive bladder for nearly 20 years.

Much of the need for neurotechnology devices and therapies has arisen because of pain. In the early days of this industry, it was chronic low back pain that drove sales of spinal cord stimulation systems—still the largest product category in the global neuromodulation market. But newer devices and therapies are targeting other forms of pain, including the intense psychic pain that accompanies major depression and other neuropsychiatric disorders.

Neuroscience and neurotechnology researchers have exploited a number of different technologies besides electrical stimulation to effect control of brain functions. These include ultrasound, transcranial magnetic stimulation, and optogenetics. Recently, a team of investigators in Korea demonstrated a potentially new form of neuromodulation called magnetogenetics. Researchers at the Center for Nanome…

Bioelectronic medicine systems have offered novel therapeutic interventions for a number of indications over the last several years. But there is also a significant market opportunity for diagnostic systems that incorporate principles of bioelectronic medicine. Recently, a research team from the University of California San Diego reported progress on one such system that may prove useful in detecting sepsis and other serious medical conditions.